UAMS Myeloma Center
The UAMS Myeloma Center is the most comprehensive center in the world for research and clinical care related to multiple myeloma and related diseases, such as Castleman Disease and Waldenstrom Macroglobulinemia. Our team of leading scientists and clinicians has pioneered many advances that have become standards of care, leading to improved survival rates. The Myeloma Center is known for its “bench to bedside” approach, continually translating advances in the laboratory into breakthrough clinical treatments.
Total Therapy Approach
At the core of the successful outcomes at the Myeloma Center is a treatment approach that combines chemotherapy with autologous stem cell transplantation followed by a maintenance strategy.
Learn moreWinter/Spring 2022 Myeloma Magazine
The goal of Myeloma is to provide timely updates about progress in clinical treatment and research advances, as well as stories and information of general interest.
Read MagazineMyeloma Center: Study Puts More Than 50 UAMS Faculty Among Top 2% of Influential Researchers
LITTLE ROCK — A study by Stanford University lists over 50 current and retired UAMS faculty among the top 2% of most influential researchers. The study is based on an analysis of Scopus, the largest database of peer-reviewed research literature. To determine the most influential researchers, the study authors used a combination of citation metrics…
News & Announcements
Danyelle Musselman to Emcee UAMS Winthrop P. Rockefeller Cancer Institute’s ‘Be a Part of the Cure’ Walk on April 30
On April 30, the first lady of Arkansas Razorback Men’s Basketball, Danyelle Musselman, will emcee the UAMS Winthrop P. Rockefeller Cancer Institute’s “Be a Part of the Cure” Walk honoring all Arkansas cancer patients.
Read more
Winthrop P. Rockefeller Cancer Institute’s Radiation Oncology Center Becomes First and Only Center in Arkansas to Earn APEx Accreditation
The Radiation Oncology Center at the University of Arkansas for Medical Sciences (UAMS) has received the highest national accreditation from the American Society for Radiation Oncology (ASTRO). The center, which is part of the UAMS Winthrop P. Rockefeller Cancer Institute, is the only radiation oncology center in the state to be granted full accreditation by…
Read more
First Myeloma Center Patient Receives Revolutionary New Therapy, Responds Well
Dave Puente of Elk Grove, California, became the first myeloma patient in Arkansas to receive the new chimeric antigen receptor (CAR) T-cell immunotherapy at the University of Arkansas for Medical Sciences (UAMS) Myeloma Center, the only medical facility in Arkansas currently offering the cutting-edge treatment.
Read more
Pioneering Researcher Returns to UAMS Myeloma Center
John D. Shaughnessy, Jr., Ph.D., has rejoined the Myeloma Center in the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) as a principal staff scientist and professor of medicine. “It feels great to be back,” said Shaughnessy, whose research is focused on developing new targeted therapies for multiple myeloma,…
Read moreWant to read more stories like these?